A
Akari Therapeutics - ADR (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics - ADR (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD0.93
- USD0.98
- USD0.93
- USD3.15
- 17.70%
- --
- 46.44k
- 356.61k
- 30M
- 0.57
- -64.80%
Stock News
yesterday
Where Penn State football coach James Franklin’s $49 million buyout ranks among the biggest of all time
MarketWatch
yesterday
Musk calls for federal troops in San Francisco even as Benioff softens stance
CNBC
yesterday
Butterfield to Announce Third Quarter 2025 Financial Results on October 28, 2025 and Host Earnings Conference Call on October 29, 2025
Yahoo
yesterday
Why DuPont's electronics business has the most potential after next month's split
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
